Towards Multispecific Anti-Gp120 Artificial Antibody.

Area of Science:

• Biotechnology and Nanomedicine
• Immunology and Virology

Background:

• Broadly neutralizing antibodies are key therapeutics for blocking viral entry.
• Viruses like HIV rapidly mutate, leading to immune evasion of therapeutic antibodies.
• Multispecific antibodies and antibody combinations can overcome immune evasion but face development barriers and high costs.

Purpose of the Study:

• To create novel gold nanoparticle (AuNP)-based artificial antibodies (goldbodies) with enhanced binding capabilities.
• To demonstrate the feasibility of creating multispecific goldbodies by grafting multiple antibody fragments onto a single AuNP.
• To develop a cost-effective alternative to traditional multispecific or combined antibody therapies.

Main Methods:

• Grafting of the CD4 protein's HIV gp120-binding fragment onto AuNPs to create monospecific goldbodies.
• Grafting of CDR3 loops from three anti-gp120 antibodies onto AuNPs.
• Co-grafting of multiple functional fragments (CD4 fragment and CDR3 loops) onto the same AuNP to create a single, multispecific goldbody.

Main Results:

• Successfully created four distinct monospecific anti-gp120 goldbodies.
• Demonstrated for the first time that multiple different functional fragments can be simultaneously grafted onto a single AuNP.
• The resulting multispecific goldbodies exhibit high binding affinity for gp120.

Conclusions:

• A novel class of multispecific goldbodies can be engineered by co-grafting multiple antibody fragments onto AuNPs.
• This approach offers a potentially low-cost method for producing artificial antibodies with enhanced therapeutic potential against viral evasion.
• These engineered goldbodies represent a promising proof-of-concept for advanced antibody-based therapeutics.